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The transcriptional properties of unliganded thyroid hormone receptors are thought to cause the
misdevelopment during hypothyroidism of several functions essential for adult life. To specifically determine
the role of unliganded thyroid hormone receptor 1 (TR1) in neuronal tissues, we introduced a mutation into
the mouse TR1 gene that lowers affinity to thyroid hormone (TH) 10-fold. The resulting heterozygous mice
exhibit several distinct neurological abnormalities: extreme anxiety, reduced recognition memory, and
locomotor dysfunction. The anxiety and memory deficiencies were relieved by treatment with high levels of
TH in adulthood, an effect that correlated with a normalization of GABAergic inhibitory interneurons in the
hippocampal CA1 region. In contrast, a post-natal TH treatment was necessary and sufficient for ameliorating
the adult locomotor dysfunction. Here, the hormone treatment normalized the otherwise delayed cerebellar
development. The data thus identify two novel and distinct functions of an unliganded TR1 during
development and adulthood, respectively.
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Thyroid hormone (TH) is required for development of
normal brain function. The effects of TH are mediated by
the nuclear hormone receptors, encoded by the thyroid
hormone receptor (TR)  and  genes in vertebrates. Like
many nuclear hormone receptors, TRs exert potent tran-
scription regulatory functions by acting not only as li-
gand–receptor complexes but also as apo-receptors. In
the absence of ligand, TRs recruit transcriptional core-
pressors such as N-CoR or SMRT, thereby suppressing
the innate basal level of target gene expression (Glass
and Rosenfeld 2000). The binding of ligand causes release
of corepressor and subsequent recruitment of factors re-
quired for gene expression above basal levels.
In endemic cretinism, severe iodine deficiency during
pregnancy results in insufficient supply of thyroid hor-
mone to the fetus during critical stages of neuronal de-
velopment. This, in turn, leads to irreversible motor
dysfunctions combined with mental retardation (De-
lange 1996). Untreated congenital hypothyroidism,
which affects neuronal events occurring later than those
causing endemic cretinism, leads to delayed post-natal
development along with reduced mental capability (De-
lange 1996). Whether these deficiencies are caused by
insufficient activation of target genes or by outright tran-
scriptional repression by apo-receptors has been unclear.
Recent evidence, however, suggested that mice devoid of
all thyroid hormone receptor genes exhibit far fewer fea-
tures of hypothyroidism as compared with mice made
congenitally hypothyroid by treatment with thyrostatic
drugs (Gauthier et al. 1999; Go¨the et al. 1999), thus im-
plicating TR apo-receptors as a cause of the detrimental
effects of hypothyroidism. Indeed, subsequent genetic
analyses identified the TR1 apo-receptor as a general
contributor to delayed post-natal maturation (Flamant et
al. 2002) and cerebellar development in particular (Morte
et al. 2002).
More than 300 patient families suffering from the syn-
drome of Resistance to Thyroid Hormone (RTH) have
been shown to have mutant TR genes that encode a
receptor with reduced affinity to ligand and dominant-
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negative properties. These patients display only weak
neurological symptoms, in agreement with the concept
that TR1 is more relevant in central nervous system
maturation and function than TR. No patient with a
germline mutation in TR1 has been found, raising the
possibility that TR1 mutations are lethal. However,
mutations in human TR found in RTH have been trans-
ferred to the mouse TR1 gene, causing retarded post-
natal development, bradycardia, metabolic dysfunctions,
and inappropriately elevated serum TSH (Kaneshige et
al. 2001; Tinnikov et al. 2002; Liu et al. 2003). Since
∼70%–80% of TR in neuronal tissues is TR1 (Ercan-
Fang et al. 1996), we have here addressed the function of
this receptor in governing neuronal development and
adult brain function. By using mice expressing a domi-
nant-negative TR1 with a 10-fold lower affinity to T3
(Tinnikov et al. 2002), we have identified two distinct
effects of TR1. Firstly, the mice present an unusually
prominent anxiety, which required an adult, ongoing
treatment with T3 for amelioration. This treatment also
normalized the pattern of GABAergic inhibitory inter-
neurons in the CA1 region of the hippocampus, suggest-
ing that TR1 exerts a novel, adult neurophysiological
role. Secondly, the mice exhibit an adult locomotor dys-
function that correlates with a post-natal delay in cer-
ebellar development. Juvenile but not adult treatment
with high levels of T3 normalized the locomotor activity
in the adult mouse as well as accelerated their post-natal
cerebellar development.
Thus, the analysis of the mutant mice identified two
operationally distinct functions of TR1 in behavior, and
correlated each of them to specific and separate develop-
mental events in the brain.
Results
Exploratory activity and anxiety-related behavior
Since hypothyroidism in the adult is associated with
mood disorders in man and elevated anxiety in the rat,
we tested the hypothesis that a mutant TR1 with a
lower affinity to ligand would cause similar deficiencies
in the mouse. For this we used knock-in mice harboring
such an allele, the TR1R384C mutant, that exerts a
dominant-negative effect in heterozygotes (Tinnikov et
al. 2002). Exploratory behavior of 12–14-wk-old male
heterozygous mice (TR1+/m) was examined in a novel
environment, by subjecting them to the open field test.
Figure 1A shows that 12–14-wk-old TR1+/m mice ex-
hibited a reduced exploratory activity in a brightly lit
open field arena compared with wild-type mice, as indi-
cated by a lower total distance traveled (horizontal ac-
tivity; P < 0.001) and a reduced number of rearings (ver-
tical activity; P < 0.01) during the testing session. More-
over, in contrast to wild-type mice, mutant mice
exhibited a pronounced tendency for retropulsion (data
not shown) and a strongly increased freezing behavior
(31% vs. 1.8%) (Fig. 1A, right panel). Interestingly, the
freezing behavior exhibited by mutant mice was accom-
panied by an enhanced sympathetic reactivity as indi-
cated by the higher number of fecal boli compared with
wild-type animals (6.2 vs. 2.1; P < 0.05). Given that the
decrease in locomotion and the high freezing behavior
that TR1+/m mice displayed in the arena can be inter-
preted as an increase in anxiety-like behavior (Crawley
and Paylor 1997), we decided to use a more specific test
for evaluating anxiety-related behavior: the elevated plus
maze.
Figure 2A shows that TR1+/m mice exhibited in-
creased anxiety-like behavior in the elevated plus maze,
as they spent less time in the open arms as compared
with wild-type mice (P < 0.001). In addition, the mutant
mice showed a lower number of center crossings
(P < 0.0001) and rearings (P < 0.0001) than controls, indi-
cating a reduced exploratory activity in this test. As pre-
Figure 1. Exploration and anxiety as determined in the open
field test. Total distance traveled, number of rearings, and per-
centage of freezing behavior were evaluated during 10 min in
the open field. (A) Untreated TR1+/m mice (n = 16) showed a
lower exploratory activity and higher freezing behavior com-
pared with wild-type control (n = 9) mice. (B) TR1+/m (n = 7)
mice treated with T3 as adults showed a normal exploratory
behavior in the open field compared with wild-type mice (n = 9).
(C) Injection of T3 during P10–P35 failed to normalize the ex-
ploratory behavior of TR1+/m mice (n = 6 for both mutant and
wild-type [wt] animals). All parameters were analyzed by means
of a two-way (“genotype” × “T3 treatment”) ANOVA. Post hoc
analysis showed that there was a statistically significant differ-
ence between mutant mice treated with T3 as adults and un-
treated mutant mice (all P < 0.05, Tukey’s test). Data are pre-
sented as means ± SEMs; (*) P < 0.05; (**) P < 0.01; (***)
P < 0.001.
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viously observed in the open field, the mutant mice ex-
hibited a high percentage of freezing behavior (43.9% vs.
5.5%; P < 0.0001) during the exposure to the elevated
plus maze.
To investigate if high TH levels could restore the be-
havioral alterations observed in adult TR1+/m mice, an-
other group of animals was treated with hormone by
addition of T3 to the drinking water of adult mice for 12
d, or by injecting juvenile mice during their post-natal
development (post-natal days 10– 35 [P10–P35]). The ju-
venile mice were then tested when adult. Figure 1B (left
and center panels) shows that T3 treatment during adult-
hood abolished the differences between wild-type and
mutant mice in exploratory activity of the open field
test. Two-way ANOVA revealed a significant interaction
between “genotype” and “treatment” for freezing behav-
ior in the open field test [F(2,46) = 3.93; P < 0.05], but not
for distance traveled [F(2,46) = 1.86; P = 0.13] or rearing
behavior [F(2,46) = 0.01; P = 0.99]. A post hoc analysis in-
dicated that freezing levels were still higher in T3-mu-
tant mice treated as adults compared with corresponding
T3-treated wild-type mice (Fig. 1B, right panel). How-
ever, this treatment significantly attenuated freezing
levels in mutant mice as compared with untreated mu-
tant mice (P < 0.0001, Tukey’s test). In the elevated plus
maze, T3 treatment during adulthood also normalized
several behavioral parameters (percentage of time in the
open arms of the maze, center crossing, and freezing) in
mutant mice, although significant differences were still
observed in the number of rearings (P < 0.05, Tukey’s
test) (Fig. 2B). In contrast, the T3 treatment during P10–
P35 failed to ameliorate any of the behavioral alterations
(exploratory activity and anxiety) described in untreated
mutant mice (Figs. 1C, 2C). We conclude that the in-
creased anxiety is readily reduced by T3 only in the adult
animal.
Novel object recognition task
We used the novel object recognition task (Ennaceur and
Delacour 1988) to measure visual recognition memory, a
model of declarative memory that depends on hippocam-
pal function (Myhrer 1989; Pittenger et al. 2002). This
task takes advantage of a rodent’s natural tendency to
explore novel objects. Thus, no negative or positive re-
inforcers need to be applied that may interfere with the
memory performance (e.g., swimming-induced stress in
the Morris water maze). In addition, locomotor ability is
not a critical factor in this task, in contrast to other
hippocampal-dependent tasks like the Morris water
maze. During training there was no significant difference
between genotypes in the exploratory preference of the
novel objects (data not shown). At the retention test (1 d
later), one of the familiar objects used in the training
Figure 2. Anxiety-like behavior in the elevated plus maze test.
(A) Untreated TR1 mutant mice (n = 16) showed an increased
anxiety behavior compared with wild-type controls (n = 9) mice.
(B) TR1+/m (n = 7) mice treated with T3 as adults significantly
ameliorated anxiety-like behavior in the elevated plus maze
compared with wild-type mice (n = 9). (C) Injection of T3 during
P10–P35 did not alleviate anxiety-like behavior of TR1+/m
(n = 6) compared with wild-type (n = 6) mice. Data were ana-
lyzed by means of a two-way (“genotype” × “T3 treatment”)
ANOVA. Post hoc analysis showed that there was a statistically
significant difference in the measured variables between mu-
tant mice treated with T3 as adults and untreated mutant mice
(all P < 0.01, Tukey’s test). Data are presented as means ± SEMs;
(*) P < 0.05; (**) P < 0.01; (***) P < 0.001.
Figure 3. Normalization of visual recognition memory by
adult T3 treatment as measured by the novel object recognition
task. TR1 mutant mice (n = 12) showed a reduced exploratory
preference in the object recognition task compared with wild-
type control mice (n = 9). Mutant untreated mice displayed a
memory impairment in this task since the discrimination ratio
did not differ from the chance level [t(11) = 12.7, P < 0.0001].
TR1+/m (n = 5) mice treated with T3 as adults showed a similar
preference for the new object as wild-type treated mice (n = 8)
and performed significantly better in this task than mutant un-
treated mice. Injection of T3 during P10–P35 failed to improve
object recognition memory in TR1+/m (n = 8) compared with
wild-type (n = 6) mice. The dashed line represents equal explo-
ration of the novel and familiar objects (50%). Data were ana-
lyzed by means of a two-way (“genotype” × “T3 treatment”)
ANOVA. Data are presented as means ± SEMs; (*) P < 0.05; (**)
P < 0.01; (***) P < 0.001.
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session was replaced with a novel object, and the ani-
mals’ behavior was videotaped during 5 min for later
analysis. As indicated in Figure 3, marked differences
were found in the response of mutant and wild-type ani-
mals to the presentation of a novel object. Two-way
ANOVA indicated a significant “genotype” effect in the
preference for the novel object, [F(1,42) = 11.09, P < 0.002],
but not a significant “genotype” × “treatment” interaction
[F(2,42) = 1.82, P = 0.17, n.s.]. A post hoc analysis using
Dunnett’s test revealed a significant difference in the
object recognition test between untreated mutant and
wild-type mice (P < 0.01). Moreover, mutant mice did
not exhibit novel object preference during the test ses-
sion (49.7%), since the discrimination index did not dif-
fer from the chance level [t(11) = 0.88; P = 0.98, n.s.]. In-
terestingly, mutant mice that were treated with T3 dur-
ing adulthood showed a clear exploratory preference for
the novel object (64.8%) similar to that seen with the
wild-type controls (68.0%, P = 0.53), and which was sig-
nificantly higher than that observed with untreated mu-
tant mice (P < 0.05). In contrast, mutant mice treated
with T3 as juveniles still showed a lower object recog-
nition memory index (58.1%) compared with wild-type
mice (67.3%; P < 0.05).
Alterations in hippocampal GABAergic interneurons
Previous analyses showed that mice lacking the TR1
gene (TR1−/− mice) showed anxiety in the open field
and enhanced fear in the contextual fear conditioning
test. These mice also presented a reduction in the den-
sity of GABAergic terminals from interneurons of the
CA1 region in the hippocampus (Guadan˜o-Ferraz et al.
2003). We therefore examined the TR1+/m mice for the
presence of similar alterations in inhibitory cortical cir-
cuits by analyzing the immunostaining patterns for par-
valbumin (PV). PV is a Ca2+-binding protein that labels
the subpopulation of GABAergic interneurons (chande-
lier and basket cells) (Celio et al. 1986) representing the
most powerful inhibitory neurons of the cerebral cortex.
In the hippocampus they are the main cells implicated in
perisomatic control of pyramidal cells, and their somata
are mainly localized in the strata pyramidale and oriens
(Freund and Buzsaki 1996; DeFelipe 1999). Figure 4A
shows a comparison of immunohistochemical staining
between normal and mutant animals, and the result of
T3 treatment. In the untreated wild-type animals, PV-
immunoreactive neuronal bodies were clearly seen (ar-
rowheads). The axon terminals of these cells were also
stained, resulting in a punctate appearance, ending on
the cell bodies of pyramidal neurons, which delimit a
clear, stain-free region (Fig. 4A, asterisks). Expression of
the mutant receptor was associated with a lower number
of PV-immunoreactive neurons as shown in Table 1. The
mutant mice displayed a 40%–50% reduction in the
number of PV-positive cell bodies. In addition, they
showed a significantly lower immunohistochemical
staining (Fig. 4A; Table 1), indicating a decreased density
of terminals and therefore a reduced inhibitory synaptic
innervation of pyramidal cells. A similar pattern was
found using immunofluorescence, as illustrated in Fig-
ure 4B. Adult treatment of the mice for 12 d with high
levels of T3 in the drinking water prior to analysis nor-
malized the number of cells and the staining pattern (Fig.
4A; Table 1).
The lower density of PV terminals was probably due to
the lower number of PV-immunoreactive neurons, al-
though an effect of the mutant receptor on PV expression
cannot be discarded. Quantification of the total number
of GABAergic cells in the CA1 region, after in situ hy-
bridization with digoxigenin-labeled probes for the two
isoforms of glutamic acid decarboxylase (data not
shown), indicated a reduction in the number of cells in
the mutant mice (108 ± 5) as compared with the wild-
type mice (118 ± 3, P < 0.05). The experiments thus in-
dicate that the high anxiety and the reduced exploratory
behavior correlate with an adult, neurophysiological ef-
fect imposed by the mutant receptor.
Table 1. Number of parvalbumin-positive cells and density
of parvalbumin-positive terminals in the hippocampus
Mice
PV+ neuronsa PV+ terminal
density
(arbitrary units)Experiment 1 Experiment 2
Wild type 37 ± 4 (n = 2) 24 ± 0 (n = 2) 1.94 ± 0.03 (n = 3)
Wild type
+ T3 40 ± 1 (n = 3) 26 ± 4 (n = 3) 1.76 ± 0.16 (n = 3)
+/m 22 ± 4 (n = 4)b 13 ± 2 (n = 3)b 1.25 ± 0.09 (n = 3)b
+/m + T3 39 ± 4 (n = 3) 25 ± 2 (n = 3) 1.69 ± 0.09 (n = 3)
aPV+ neurons: The number of parvalbumin-positive cell somata
was counted in the CA1 region of the hippocampus, in two
different experiments. PV+ terminal density in the pyramidal
layer was measured as indicated in Materials and Methods. The
number of animals used for each measurement is indicated.
bANOVA indicated that the differences were significant when
comparing the data from the +/m mice to the untreated wild-
type or T3-treated mice. There were no differences when wild-
type, wild-type + T3, or +/m + T3 mice were compared with one
another.
Figure 4. Reduced number of PV-ir terminals in the CA1 re-
gion in the mutant mice. This figure shows sections of the
dorsal hippocampus of wild-type and mutant mice immuno-
stained for PV and developed by the peroxidase method (A) or by
immunofluorescence (B). The density of PV-ir perisomatic ter-
minals is lower in the untreated mutant mice (+/−) than in the
wild-type mice (wt). T3 treatment did not modify the wild-type
pattern, whereas it increased the mutant mice pattern as shown
in A. In B, the same difference in the density of terminals, as
revealed by immunofluorescence, is observed between the un-
treated wild-type and mutant mice.
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Impaired locomotor activity
Since congenital hypothyroidism in rodents is well
known to cause cerebellar misdevelopment and im-
paired locomotor activity, we tested the hypothesis that
the mutant TR1 would cause similar deficiencies. Male
mice, 12–14 wk old, were trained on the Rotarod and
then tested for their ability to stay on the accelerating
rod. Figure 5A (left panel) shows that the mutant male
animals (TR1+/m) had a significantly reduced capacity.
No difference was seen between wild-type and mutant
female mice (data not shown).
The TH-sensitive period of cerebellar development oc-
curs mainly post-natally in the mouse. Since the mutant
receptor used had a reduced but not abolished affinity for
T3, we tested if post-natal injections of TH would rescue
normal locomotor ability. Accordingly, 10-d-old pups
were injected i.p. daily with a 1:10 mixture of T3 and T4
(25 and 250 µg/kg body weight, respectively) for 25 d
(P10–P35), whereafter the injections were stopped. Hor-
mone injections rapidly but transiently increase thyroid
hormones in serum to very high levels (Wikstro¨m et al.
1998) and result in transcriptional regulation of target
genes also by the mutant TR1 (Tinnikov et al. 2002).
However, the injection regimen used here allows the free
serum hormone levels to decrease to near normal after
24 h in young mice (data not shown). The proficiency on
the Rotarod was determined when the mice were 12–14
wk old. The results show (Fig. 5A, middle panel) that
such a treatment fully restored locomotor ability. In con-
trast, treatment only during adulthood by addition of T3
to the drinking water (0.5 µg/mL) for 12 d and during the
test failed to enhance the locomotor ability of the mu-
tant mice (Fig. 5A, right panel).
The data above indicated that the mutant TR caused
deficiencies similar to those seen in congenital hypothy-
roidism. Histological analyses of the adult mutant cer-
ebellum revealed no obvious abnormalities (data not
shown). However, as hypothyroidism causes a transient
delay in the post-natal migration of cerebellar external
granular (EGL) cells to the internal granular layer (IGL),
we compared the thickness of the developing EGL of
wild-type and mutant mice between P14 and P21 as well
as monitored the ability of injected TH to accelerate the
process. Figure 5B, upper panels, shows that among the
untreated animals, the mutant mice had a delay of 4–6 d.
Hormone treatment by daily injections of TH acceler-
ated development in both animal groups, suggesting that
the mutant TR1 is activated by the higher hormone
levels. Although a minor delay in Purkinje cell develop-
ment was observed in the mutant mice (Fig. 5B, lower
panel), no major perturbations were seen in the cellular
arborization, as expected since these cells are known to
express mainly TR (Strait et al. 1991; Bradley et al.
1992). Taken together, the data suggest that the domi-
nant-negative TR1 confers both a morphological and a
functional impairment to the cerebellum, which, how-
ever, could be circumvented by an appropriately timed
hormone treatment.
Effects of hormone treatment on tissues and target
genes in adult mice
Since TH treatments dramatically improved the perfor-
mance of the TR1+/m mice, we aimed to confirm that
the administration of T3 to adult animals appropriately
increased serum and tissue levels of the hormone. Adult
mice having received T3 for 12 d in the drinking water
experienced sharply decreased plasma total T4 levels as
expected (Fig. 6A). The plasma T3 levels were increased
Figure 5. Locomotor dysfunction and its amelioration by T3.
(A) Littermate wild-type (wt) and heterozygous mutant (+/m)
mice, 12–14 wk old, were trained on the Rotarod, whereafter the
time until they fall off the accelerating rod was determined. The
left section shows that mutant mice were less capable than
wild-type controls, the middle section demonstrates that injec-
tion of T3 during P10–P35 resulted in complete normalization
of the adult mutant mice, and the right section illustrates the
inefficacy of an adult, ongoing T3 treatment to improve perfor-
mance. The number of animals tested is shown in each bar.
Pairwise t-tests were used for determination of significance. (*)
P < 0.05; (**) P < 0.005. (B) The ability of post-natal injections to
accelerate cerebellar development. Littermate wild-type or mu-
tant mice were injected daily with T3, starting at P10. Three
mice were analyzed for each panel. (Upper section) Lobes IIX of
the cerebella were sectioned and stained with Nissl. Represen-
tative sections showing the external granular, molecular, and
internal granular layers are shown. (Lower section) Cerebellar
Purkinje cells of the TR1+/m mice show a delayed but other-
wise normal arborization.
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about threefold in both wild-type and the mutant mice
(Fig. 6A). The tissue concentrations (nanograms per gram
wet weight), however, showed greater increases in total
T3, ranging from seven- to eightfold in the livers and
about fourfold in the cerebella, to twofold in the cortices
(Fig. 6A). The reductions seen in the tissue concentra-
tions of T4 in all instances paralleled those seen for
plasma. The data thus confirm that the TH treatment
significantly increased plasma and tissue concentrations
of T3.
As an indication that the increased tissue concentra-
tions of T3 were translated into a biological response at
the genomic level, we analyzed the expression of a thy-
roid-hormone-regulated gene. RC3 is one of the few
known thyroid-hormone-sensitive target genes in the
adult brain and is regulated by T3, especially in the cau-
date nucleus. In addition, it is selectively induced by T3
through TR1 (Manzano et al. 2003). RC3, therefore, is a
good genomic target to verify that T3, by raised tissue
concentrations, could act through the mutant TR1. Tis-
sues from adult mutant and wild-type mice that had
been treated with TH in the drinking water for 12 d were
analyzed for RC3 expression by in situ hybridization and
compared with untreated controls. Figure 6B shows rep-
resentative autoradiographs of brain slices at the level of
the caudate nucleus (CPu). Expression in the caudate
was increased by T3 treatment both in the wild-type and
in the mutant animals, indicating that the treatment
regimen was efficacious.
Discussion
Our findings provide the first data on the specific effect
of a dominant-negative TR1 on brain function and
structure. In addition to the general developmental delay
previously described, the mice harboring the mutant
TR1 exhibit a phenotype of CNS damage that re-
sembles the behavioral and structural features of hypo-
thyroidism. Most importantly, the serum and tissue con-
centrations of T4 and T3 were normal, and the deficien-
cies were reduced or abolished by appropriately timed
treatments with high doses of thyroid hormone. This
argues that the mutant receptor, having a reduced affin-
ity to T3, caused the abnormalities by acting as an unli-
ganded TR (apo-receptor) and that ligand, when present
at sufficiently high levels, bound the mutant TR to allow
normal signaling to occur. By correlating the properties
specific to the mutant TR1 with defects in behavior and
locomotion that were ameliorated by hormone, the data
in addition identify previously unclear roles of thyroid
hormones in development and CNS function in the
adult.
Our data suggest that the dominant-negative TR1
causes two distinct major insults: a delayed cerebellar
development, resulting in adult cerebellar locomotor
dysfunction that is preventable by T3 treatment during
the period of cerebellar development; and another, a re-
duced number of GABAergic interneurons and decreased
density of GABAergic terminals in the CA1 region of the
hippocampus, which presents as increased anxiety and
reduced cognition. In contrast to cerebellar morphologi-
cal changes, alterations in hippocampal GABAergic in-
terneurons could be normalized by the adult but not the
juvenile T3 treatment.
Previously, mice with a dominant-negative TR allele
were described (Hashimoto et al. 2001). However, these
data and their interpretations are different from those
described above. TR1 and TR are known to be ex-
pressed at very different levels and in distinct regions in
the brain. The severe locomotor deficiencies reported by
Hashimoto et al. (2001) correlated with a delayed devel-
opment of cerebellar Purkinje cells, a tissue known to
express TR and little if any TR1. Furthermore, the
mutant TR used binds no hormone, and as this isoform
is critical for the pituitary–thyroid axis, the mice tested
Figure 6. Effect of hormone administration to adult mice on
tissue levels of T3 and on the target gene RC3. (A) Plasma and
tissue concentrations of T4 and T3 in untreated and T3-treated
wild-type and mutant mice. The data show concentrations of
T4 and T3 in nanograms per deciliter, as measured by radioim-
munoassay in whole plasma or tissue extracts as described in
Materials and Methods. Differences between groups were ana-
lyzed by two-way ANOVA with the following results: (Plasma
T4) F(3,38) = 26.877, P < 0.001; (Plasma T3) F(3,38) = 6.651,
P < 0.001; (Liver T4) F(3,47) = 56.594, P < 0.001; (Liver T3)
F(3,52) = 103.43, P < 0.001; (Cortex T4) F(3,25) = 54.666, P < 0.001;
(Cortex T3) F(3,26) = 63.514, P < 0.001; (Cerebellum T4)
F(3,27) = 50,68, P < 0.001; (Cerebellum T3) F(3,27) = 47.506,
P < 0.001. (B) Expression of the thyroid hormone-regulated gene
RC3 in adult wild-type and mutant mice, treated and untreated
with T3. The data were quantified by measuring the optical
density of autoradiograms in the caudate nucleus (CPu). Three
wild-type and mutant mice, treated or not with T3, were used
for quantification, and the mean values ± SD are shown as av-
erage grain density in arbitrary units. The data were analyzed by
one-way ANOVA: F(3,6) = 4.94, P < 0.05. Post hoc analysis
showed that there was a statistically significant difference
(P < 0.05) in the treated wild-type or mutant mice compared
with the untreated mice.
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had severalfold elevated serum levels of TH. Identifica-
tion of the developmental time for the insults and a
study of the effects of hormone acting via TR1 or TR
were therefore not possible. The authors also mention
that the memory impairments reported could not be un-
ambiguously ascribed to hippocampal or cortical activi-
ties of the mutant TR as the Morris water maze test
used is also sensitive to deficiencies in locomotor func-
tion.
Locomotor dysfunctions
The male TR1+/m mice exhibited a significant reduc-
tion in motor coordination as assessed by the Rotarod
test, whereas females were not affected. The reason for
the sex difference is unclear, but could be related to dif-
ferences in the effects of sex hormones on neuronal lo-
comotor functions or be due to differences in body
weight, reflecting muscle strength. For example, estra-
diol reduces neuronal damage during ethanol withdrawal
syndrome (Rewal et al. 2003). Although TR1 has been
ascribed important roles in muscle function (Johansson
et al. 2000), we consider this possibility unlikely since
determination of soleus and edl muscle function in ex-
planted tissues failed to reveal major functional dysfunc-
tions (H. Westerblad and B. Vennstro¨m, unpubl.). The
impaired locomotor activity on the Rotarod was amelio-
rated by a juvenile TH but not an adult treatment with
TH. This suggests that a major part of the insult imposed
by the mutant receptor resides in the cerebellum, since
the time for the post-natal treatment coincided with the
known TH-dependent period of cerebellar development.
This is further supported by the observation that the
maturation of the external granular layer was delayed in
the mutant mice but accelerated by TH, which is in con-
gruence with our previous demonstration that unli-
ganded TR1 selectively impairs the development of this
cell type (Morte et al. 2002). In contrast to these alter-
ations, only minor effects were seen on the cerebellar
Purkinje cells: The developing TR1+/− mice exhibited
marginally shorter dendrites but normal arborization.
Although hypothyroidism normally leads to shortening
of dendritic fibers and markedly less arborization, our
data are fully compatible with the delayed overall matu-
ration of 4–6 d seen with these animals, especially as
Purkinje cells are known to express TR and not TR1
(Strait et al. 1991). Taken together, our data implicate
the cerebellum as the target for an insult by the mutant
TR1 that caused the locomotor deficiency revealed by
the Rotarod. This conclusion is further supported by the
observations that defects in locomotion and balance are
associated with cerebellar or basal ganglia damage, as
described for many mouse strains with specific genetic
alterations (Lalonde et al. 1995).
We have also detected many additional parameters of
locomotor deficiencies in the mutant mice (M. Sjo¨gren
and B. Vennstro¨m, unpubl.). Here, the developmental in-
sult(s) occur invariably during late embryonal/early fetal
development and, as with the Rotarod parameter, affect
male mice significantly more than female. The underly-
ing tissue defect(s) are as yet unidentified.
Altered exploration and increased anxiety
The open field task was used to test for differences in the
exploratory activity of the animals in a novel environ-
ment, another parameter known to be affected by thy-
roid hormone disorders in rodents (Eayrs 1966). Mutant
TR1 mice displayed a low activity exploration com-
pared with wild-type mice. This could be influenced by
the altered locomotor coordination that these mice pre-
sent, as previously evidenced in the Rotarod test (Fig.
5A), and/or by a high anxiety-like behavior in a novel
environment (Crawley and Paylor 1997). The former pos-
sibility is unlikely since adult mutant mice treated with
TH did not show significant differences in the total dis-
tance traveled or number of rearings in the open field
when compared with controls (Fig. 1B), in contrast to the
deficit in locomotor coordination on the Rotarod (Fig.
5A). Therefore, the reduced exploratory activity dis-
played by the mutant mice on the open field and the
elevated plus maze is likely to be a consequence of a high
anxiety behavior. This possibility is supported by the
fact that, during open field (Fig. 1A) and elevated plus
maze sessions (Fig. 2A), TR1+/m mice displayed high
levels of freezing behavior accompanied by an increased
defecation, a feature that is associated with high anxiety
behavior (Gray 1971). Importantly, most of these altered
behavioral responses displayed by mutant mice were
normalized or ameliorated by a TH supplement to adult
but not juvenile animals (cf. Figs. 1B, 5B,C). In conclu-
sion, our results provide novel evidence linking genetic
variation in TR1 with cognitive and emotional pro-
cesses.
Hippocampal abnormalities
The observation that only the adult treatment with TH
ameliorated the anxiety identifies the dysfunction as one
caused by the action of the mutant receptor in the adult
brain, in contrast to the developmental effect on loco-
motor activity. Furthermore, the results of the open field
and elevated plus maze tests indicated that the defect
could be located at the level of the hippocampus, similar
to that previously seen with mice lacking TR1
(Guadan˜o-Ferraz et al. 2003). Other brain areas, particu-
larly the amygdala, play important roles in anxiety- and
fear-related behaviors (LeDoux 2000). Although at pres-
ent we cannot discard a defect at the level of the amyg-
dala, recent neuroanatomical studies suggest that the
hippocampus may have a preferential role in brain pro-
cesses associated with anxiety-related behaviors, while
the amygdala would be associated specifically with fear
(for review, see Bannerman et al. 2004). Indeed, the
TR1+/m mice showed a prominent and selective reduc-
tion of perisomatic terminals expressing the Ca2+-bind-
ing protein PV in the CA1 field of the hippocampus,
suggesting that TH affects the specification of inhibitory
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hippocampal circuitry via TR1. This is supported by
our previous demonstration (Guadan˜o-Ferraz et al. 2003)
that PV-immunoreactive interneurons in the hippocam-
pus express predominantly TR1 over TR. PV immu-
nohistochemistry in the hippocampus selectively labels
the cell bodies and axons of basket and chandelier cells
(Sik et al. 1995; Freund and Buzsaki 1996), the most pow-
erful inhibitory cells involved in regulation of efferent
activity (Miles et al. 1996). Our results indicate that
these inhibitory interneurons are affected in the mutant
mice. It is thus possible that a decreased GABAergic in-
hibition could lead to hippocampal hyperactivity, result-
ing in the increased emotionality and anxiety observed
in the mutant mice. In support of this interpretation, it is
noteworthy that mice with a disrupted gene for uroki-
nase plasminogen activator receptor show increased
anxiety probably as a consequence of diminished inter-
neuronal activity (Powell et al. 2003): These features are
accompanied by a near complete loss of parvalbumin-
positive subtype neurons with little or no effects on
other interneuronal subtypes. Our data do not allow dis-
criminating between a decrease in the number of cells or
a decrease in PV expression leading to fewer PV-immu-
noreactive neurons, although the whole population of
glutamic acid decarboxylase-expressing cells is reduced
in the CA1 field of the mutant mice.
The high anxiety/low exploration represents novel ef-
fects of a dominant-negative TR1, especially as it cor-
related with abnormalities in the hippocampal GABAer-
gic neurons involved in cognitive functions. The hippo-
campus is well known to play a role in emotion and fear-
or anxiety-related behavior (LeDoux 2000; McHugh et al.
2004). A hippocampal hyperfunction has been suggested
to lead to anxiety because of a greatly increased percep-
tion of threat in situations involving conflicting stimuli
or response alternatives (McNaughton 1997). This raises
the possibility that the reduced GABAergic input ob-
served in TR1+/m mice may be caused by reduced tonic
inhibition in the hippocampus. This could contribute
not only to the development of core behavioral symp-
toms of mood disorders, but also include deficits in novel
object recognition memory that depend on the hippo-
campus.
Object recognition impairment
Object recognition memory is a model of declarative
memory in which the hippocampus and parahippocam-
pal regions of the temporal lobe have been implicated
(Clark et al. 2000). In our study, mutant mice showed a
deficit in visual recognition memory accompanied by an
altered inhibitory input in the CA1 area of the hippo-
campus. Interestingly, this area has been indicated to
play a crucial role in long-term object recognition
memory since inactivation of this region impairs recog-
nition memory in this task after a 24-h retention interval
(Hammond et al. 2004). Moreover, a similar deficit was
found in mice with a region-specific knockout of NMDA
receptor 1 subunits in the CA1 (Rampon et al. 2000),
while transgenic mice with forebrain NMDA receptor 2B
subunit overexpression exhibit enhanced object recogni-
tion memory (Tang et al. 1999). As cognitive and mor-
phological alterations in hippocampus observed in
TR1+/m mice were normalized when animals were
treated with T3 during adulthood, it is reasonable to sug-
gest that, by regulating the GABAergic input in the CA1
area, TR1 plays a critical role for hippocampal-depen-
dent memory.
Tissue hormone levels
The mutant TR1 has previously been shown to be ac-
tivated by high levels of T3 to increase expression of
target genes, and to restore normal growth (Tinnikov et
al. 2002). The present results of thyroid hormone deter-
minations in the different tissues of mutant animals
show that the behavioral alterations are due to the domi-
nant-negative action of the mutant receptor and not de-
creased hormone concentrations leading to hypothyroid-
ism. Administration of T3 led to a significant decrease of
plasma and tissue T4, as a result of pituitary TSH inhi-
bition, in both wild-type and mutant mice, and to an
increase of tissue T3 compatible with activation of the
mutant receptor. T3 increased similarly in plasma and in
tissues in both types of animals, but the increase in tis-
sues of the mutant mice was significantly larger than in
the wild-type mice. The reason for this is unknown, but
may be caused by a lack of comparable induction, in
wild-type and mutant animals, of type 3 deiodinase, an
enzyme that degrades T4 and T3 in tissues and that is
under thyroid hormone control.
Treatment of the mutant mice with T3 increased the
tissue concentrations to levels compatible with activa-
tion of the receptor and accelerated cerebellar develop-
ment (Fig. 5). Locomotor dysfunction is known to result
from TH deficiency during the known period of TH de-
pendency for cerebellar development (Legrand 1984).
Mice lacking TR1 expression exhibit no deficiency in
the Rotarod locomotor test (B. Vennstro¨m, unpubl.), and
our results therefore indicate (1) that the apparent hypo-
thyroid feature is not caused by TH deficiency, and (2)
that the dysfunction results from a failure of the domi-
nant-negative TR1 to act upon genes involved in devel-
oping locomotor function, that is, that the mutation
causes a receptor-mediated, hypothyroid effect.
Possible relation to human disease
In patients, dominant-negative mutations in TR cause
the RTH syndrome, which is associated with pituitary
resistance leading to elevated serum levels of thyroid
hormones and goiter. Human syndromes caused by
dominant-negative TR1 have not yet been detected.
Some reports have found no mutations in TR1 despite
direct scanning for mutations in the TR1 gene that
could be associated with different psychiatric syndromes
(Feng et al. 2001). Despite this, we believe that our re-
sults raise the possibility that dominant-negative muta-
tions in TR1 in humans may have a correlate in behav-
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ior, as in the mutant mice. RTH mutations involving
TR occur at a rate of 1/50,000 births, and despite the
often considerable consequences for TH homeostasis,
heart rate, and metabolism, most of these patients ap-
pear at the clinic while presenting a goiter (Refetoff et al.
1993). Mice with the dominant-negative TR1 have nor-
mal TH levels, and association of any neurological dis-
order caused by such a receptor may not be easily recog-
nized in a clinical setting. Interestingly, a subset of pa-
tients with rapidly cycling polar disorder is refractory to
conventional treatment, unless treated with supraphysi-
ological doses of thyroid hormone (Bauer et al. 2003).
These patients show normal heart rate and no signs of
osteoporosis despite months of hormone treatment,
which has led to the notion that they exhibit a resistance
to thyroid hormone (Bauer et al. 2004). The action of
thyroid hormone on these two tissues is mediated
through TR1, raising the intriguing possibility that the
resistance of the psychiatric disease to conventional
treatment may involve TR1. Treatment of the mutant
mice with thyroid hormone improves not only growth,
but also the locomotor dysfunction, the elevated anxi-
ety, and the recognition memory impairment. Therefore
our studies suggest that if the consequences of a mutant
receptor are carefully identified, the corresponding pa-
tients can be properly diagnosed and hormone therapies
developed.
Materials and methods
Animals
The knock-in mouse strain carrying the dominant-negative
R384C mutation in TR1 was previously described (Tinnikov et
al. 2002). In short, the mutation was introduced in embryonic
stem (ES) cells (derived from 128/Ola), and the founder mice
were crossed to C57Bl/CR for at least three generations. Ani-
mals were kept on a 12-h dark–light cycle under controlled hu-
midity and temperature conditions, and had free access to water
and food. For experiments, wild-type female mice were mated
with heterozygous males of the same genetic background, yield-
ing ∼50% of wild-type and mutant offspring. Wild-type mice
were weaned at 3 wk of age, whereas mutants, due to their
delayed post-natal development (Tinnikov et al. 2002), were
weaned at 5 wk. Littermate wild-type and mutant male mice,
3–4 mo old, were used for all experiments unless stated other-
wise. All mice used were genotyped by PCR. Animal care pro-
cedures were conducted in accordance with the guidelines set
by the European Community Council Directives (86/609/EEC).
Necessary animal permissions were obtained from the appro-
priate local ethical committees.
Treatment of adult mice with thyroid hormone was done by
adding T3 to the drinking water, containing 0.01% albumin to
stabilize the hormone, at a final concentration of 0.5 µg/mL.
This solution was administered to the mice 12 d before onset of
behavioral studies and was continued during the test periods.
Juvenile T3 treatment was done by injecting a mixture of T3
and T4 daily (T3: 25 µg/kg body weight; T4: 250 µg/kg) starting
at P10 and ending at P35.
Behavioral tests
Mice used in open field or elevated plus maze tests (Current
Protocols in Neuroscience 2003) were individually housed for 3
wk before analysis. They were weighed once a week and
handled daily for 4 d before the experiment to allow habituation
to experimental manipulations. The experiments were done be-
tween 08.00 and 14.30.
A circular open field of 140 cm diameter and 32 cm height
was used. Each mouse was transferred to the center of the field,
and its behavior and locomotor activity were monitored for 5
min using a video camera and computerized system (Ethovision
1.90, Noldus IT).
The elevated plus maze apparatus consisted of two opposing
open arms (30 × 5 cm) and two opposing enclosed arms
(30 × 5 × 15 cm) with an open roof, connected by a central
square (5 × 5 cm). The maze was elevated 38 cm above floor
level. The mouse was placed on the center square facing an open
arm and allowed to freely explore the apparatus for 5 min. The
apparatus was cleaned with 0.1% acetic acid solution between
subjects. Behavior was scored using a video camera and com-
puterized system (Ethovision 1.90, Noldus IT). Behaviors scored
were open and closed arm entries (an arm entry was defined as
all four paws into an arm) and the time spent in the open arms.
Novel object recognition task
For the novel object recognition task, mice were individually
familiarized to an open-field box (35 × 35 × 15 cm) with sample
objects, in order to reduce the anxiety-related behavior that mu-
tant mice exhibit in a novel environment. The mice received
one sample-exposure session per day for three consecutive days.
In these sessions, the mouse was placed into the area with two
copies of the sample and left to explore for 5 min before it was
returned to its home cage. The light intensity was equal in the
different parts of the apparatus (∼50 lx). During training ses-
sions, two novel objects (small plastic toys (10 × 15 cm) were
placed in a symmetrical position ∼5 cm away from walls, and
the animal was allowed to explore for 5 min. The objects were
always thoroughly cleaned between sessions using a 0.1% ace-
tic acid solution. A preference index, a ratio of the amount of
time spent exploring any of the two objects (training session) or
the novel object (retention session) over the total time spent
exploring both objects, was used to measure recognition
memory. Exploration was defined as follows: directing the nose
to the object at a distance of no more than 2 cm and/or touching
the object with the nose. Novel and familiar object location was
counterbalanced across animals.
Rotarod tests
Mice were housed three to five together from weaning. Twelve-
to 14-mo-old mice were trained for three consecutive days by
allowing them to run three times daily on the accelerating rod.
Testing was done on the fourth and fifth days (three runs each
day), and the time an individual animal stayed on the rod was
averaged. The animals had been habituated to the experimental
environment and personnel prior to testing. The Rotarod was
purchased from Panlab SL.
Hormone assays
Thyroid hormone concentrations in plasma, liver, cerebral cor-
tex, and cerebellum were determined by radioimmunoassay us-
ing whole plasma or tissue extracts as described (Escobar-Mor-
reale et al. 1996).
Tissue analyses
Mice to be used for histological analyses were anesthetized by
intraperitoneal injection of a mixture of ketamine (4 mg/100 g
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body weight) and metedomidine (15 mg/100 g body weight) or
with Avertin. The mice were perfused transcardially with 4%
paraformaldehyde in 0.1 M phosphate buffer (PB) at pH 7.4.
Analyses of cerebellar structures were done as previously de-
scribed (Morte et al. 2002). For analyses of hippocampal struc-
tures, the brains were removed, post-fixed overnight in the same
solution, and dissected across the midline for analysis of hippo-
campal structures. The left hemibrain was processed for in situ
hybridization and the right for immunohistochemistry. A total
of four wild-type and TR1+/m and three wild-type and T3-
treated TR1+/m were used. The hemibrains were cut serially at
50 µm on a vibratome in the coronal plane. Sections were pre-
treated with a solution of 10% methanol and 3% hydrogen per-
oxide (Merk, 107210) in PB to remove endogenous peroxidase
activity, then preincubated in a blocking solution (3% normal
horse serum [Vector Laboratories, S-2000], 0.1% Triton X-100
[Merk, 86031000], and 4% BSA in PB) for 2 h at room tempera-
ture. Sections were then incubated overnight at 4°C in the
above solution containing primary monoclonal mouse anti-PV
(1/4000; Sigma, C-8666). The sections were subsequently
washed in PB, incubated in a species-specific biotinylated anti-
body (Vector Laboratories, BA-2020), diluted 1:200 in PB for 1 h
at room temperature, and processed by the avidin-biotin-peroxi-
dase method. Sections were mounted on glass slides, dehy-
drated, cleared in xylene, and coverslipped. For microscopy we
used a Nikon Elite optical microscope equipped with a Nikon
dn 100 digital camera. Immunofluorescence was carried out us-
ing streptavidin Alexa Fluor 488 after incubation with biotinyl-
ated secondary antibody, and the sections were counterstained
with DAPI. For microscopy we used a Leica TCS SP2 confocal
microscope (Leica Microsystems). Comparisons between ani-
mals were made using sections incubated simultaneously in the
same well.
Counts of PV- or glutamic acid decarboxylase (GAD)-labeled
somata were performed in the CA1 field of the dorsal hippo-
campus. All strata from stratum oriens to stratum lacunosum-
moleculare were included in the analysis. The total number of
cells in three areas of 0.275 mm2 of each section was counted
directly from light microscope slides using the same counting
frame. Two to five sections from each animal were analyzed in
this way.
Quantitative measurements of the density of PV immunore-
active terminals in the hippocampal CA1 region were perfomed
by using the Neurolucida software (MicroBrightField, Inc.).
Three animals per group were analyzed. From each individual
animal, B/W images were captured from five randomly selected
microscope fields from the stratum pyramidale at high magni-
fication (100×). Similar measurements were made in the white
matter for background subtraction. The cell bodies from PV-
stained cells were excluded from the measurements.
In situ hybridization
In situ hybridization was performed on floating sections follow-
ing procedures previously described in detail (Bernal and
Guadan˜o-Ferraz 2002). The RC3 sense and antisense riboprobes
were synthesized from the cDNA template of RC3 spanning
nucleotides 253–486 in the presence of 35S[UTP]. For quantita-
tion, the autoradiographs were scanned and densitometry was
measured with the AnalySIS software (Soft Imaging System
GmbH). Sections from three animals of each group, that is,
wild-type and TR1+/m, treated, and untreated with T3, were
used. In situ hybridization for GAD was performed to label the
whole GABAergic cell population. A mixed, GAD65 and GAD67,
digoxigenin-labeled riboprobe was used.
Statistical analyses
The data on the Rotarod experiments were subjected to the
Student’s t-test to check for differences between groups. Behav-
ioral data were analyzed by two-way ANOVA with between-
subjects factors for genotype and TH treatment. Post hoc analy-
ses were performed using Tukey’s test. All other data were sub-
jected to one-way ANOVA and the protected least-significant
differences test (LSD) for multiple comparisons, after validation
of the homogeneity of variances by the Bartlett-Box F test. The
Student’s t-test was used to verify that novel object preference
was above chance (50%). Differences were considered signifi-
cant when P < 0.05. Calculations were performed using the
SPSS statistical package (SPSS Inc.).
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